Home › Spinal Cord Injuries › NCT05705453
Epidural Stimulation After Neurologic Damage: Long-Term Outcomes
Recruiting
Who can join
Ages 22 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * 22 years of age or older * Able to undergo the informed consent process * Stable spinal cord injury * International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) neurologic level of injury below C5 * No ventilator dependency within the last year * American Spinal Injury Association (AISA) imparement scale"A" or "B" in the absence of spinal cord stimulation * Medically stable in the judgment of the Principal investigator * Greater than 1 year since initial injury and at least 6 months from any required spinal instrumentation and 2 months from spinal cord stimulator surgery * Has an existing and functional implanted spinal cord stimulator system that is FDA approved and can be corroborated by hospital documentation * Spinal imaging of the stimulator system Exclusion Criteria: * Current and anticipated need for opioid pain medications or pain that would prevent full participation in the rehabilitation program in the judgment of the principal investigator * Use of botulinum toxin (Botox) injections in the previous six months * Clinically significant mental illness in the judgment of the principal investigator * Other conditions or medications that would make the subject unable to participate in testing/rehabilitation in the judgment of the principal investigator * Nonfunctional spinal cord stimulator or near end-of-life, determined by the PI * Current Pregnancy * Current pain relief from the spinal cord stimulator if the indication for implantation was for management of chronic pain.
About the study
This study will evaluate the long-term effect of chronic spinal cord stimulation to restore volitional movement for patients with chronic spinal cord injuries.
What is being tested
- Epidural Spinal Cord Stimulation (device)
Sponsor: University of Minnesota · Participants: 50 · Started: May 11, 2023
Contact the study team
- Study Coordinator · Phone: 612-873-9113
- Study Coordinator · Phone: 612-873-9113
Official record on ClinicalTrials.gov — NCT05705453
Locations in the U.S.
| Minnesota | Hennepin County Medical Center, Minneapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.